ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 107 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170 | -19.4% | 8,484 | +13.5% | 0.00% | -50.0% |
| Q2 2023 | $211 | +88.4% | 7,473 | +14.5% | 0.00% | +100.0% |
| Q1 2023 | $112 | -25.8% | 6,526 | -12.8% | 0.00% | 0.0% |
| Q4 2022 | $151 | -99.9% | 7,481 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $162,000 | -4.1% | 7,481 | +24.1% | 0.00% | 0.0% |
| Q2 2022 | $169,000 | -38.3% | 6,026 | +1.4% | 0.00% | 0.0% |
| Q1 2022 | $274,000 | -74.5% | 5,945 | -53.5% | 0.00% | -50.0% |
| Q4 2021 | $1,074,000 | +152.7% | 12,774 | +100.2% | 0.00% | 0.0% |
| Q3 2021 | $425,000 | +27.2% | 6,381 | +1.6% | 0.00% | +33.3% |
| Q2 2021 | $334,000 | +55.3% | 6,278 | +51.4% | 0.00% | -62.5% |
| Q4 2020 | $215,000 | – | 4,148 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |